[The diagnosis and treatment of bladder cancer metastases].
The study included 27 patients with regional and distant metastases of bladder cancer. Regional and distant metastases were detected in 12 (44.4%) and 15 (55.6%) patients, respectively. Basic treatment consisted in chemotherapy (MVAC scheme) which combined with reaferon immunotherapy. Chemoimmunotherapy in combination with radiotherapy was used in 8 patients to relieve pain caused by the metastases. The response was seen in 37% of patients with regional metastases and 22% of patients with distant ones. The former and the latter were followed up for 15.9 and 9.3 months, respectively.
Kariakin
O B
OB
Grishin
G N
GN
Volodina
T V
TV
D000328:Adult; D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D001706:Biopsy; D001859:Bone Neoplasms / Q000175:diagnosis / Q000188:drug therapy / Q000556:secondary*; D002945:Cisplatin / Q000008:administration & dosage; D004317:Doxorubicin / Q000008:administration & dosage; D005260:Female; D006801:Humans; D008198:Lymph Nodes / Q000473:pathology; D008207:Lymphatic Metastasis; D008297:Male; D008727:Methotrexate / Q000008:administration & dosage; D008875:Middle Aged; D009367:Neoplasm Staging; D012074:Remission Induction; D012983:Soft Tissue Neoplasms / Q000175:diagnosis / Q000188:drug therapy / Q000556:secondary*; D001749:Urinary Bladder Neoplasms / Q000175:diagnosis / Q000188:drug therapy / Q000473:pathology*; D014747:Vinblastine / Q000008:administration & dosage
D014747:Vinblastine; D004317:Doxorubicin; D002945:Cisplatin; D008727:Methotrexate